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Perhaps, only in a few Scandinavian countries as Norway
or Iceland, repeatedly ranked as the two highest HDI, it
would be not much daring to try to implement such polemic
strategy to increase organ supply.
For the moment, the universal rule has to remain as
always preached and proposed by the US and other
developed countries: a strong condemnation of organ
commerce and endorsement to incentives aiming to increase
organ supply from deceased donations.
Drs EA Friedman and AL Friedman end their review
suggesting that the debate in which they endorse the strategy
of organ commerce ‘is better than doing nothing more
productive than complaining’. As well stated by Dr FL
Delmonico ‘y endorsement of payment for organs could
propel other countries to sanction an unethical and unjust
standard of immense proportionsy’.4 We are quite con-
vinced that before embarking in this polemic and dangerous
adventure of legitimate organ commerce, it is necessary to
recognize the fragility of our ‘strategies’ when applied into a
world where socioeconomic inequalities prevail and poverty
does not respect boundaries.
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Abbud-Filho et al.1 present their argument that payment
for donor kidneys whether to a deceased donor’s family
or a living donor must be viewed negatively as exploitation
of vulnerable people. Terming the case for legitimizing
and regulating kidney sales ‘naı¨ve’ and ‘simplistic’, Abbud-
Filho et al. omit mention of the 17 Americans who die
each day, while waiting for as long as 10 years, with 91 851
others (as of 2 April 2006), for a deceased donor organ
transplant.
Translating accomplishments in Brazil, with a popula-
tion of 186 million, attaining an actual deceased donor
rate of 8 per million in 2005, to the United States with a
population of 296 million would yield 2368 deceased
donors, whereas in 2005, the United Network for Organ
Sharing reported that a total of 7593 deceased kidney
donors were actually utilized in the United States. From
another perspective, despite nationwide public education
campaigns and adding willingness to be an organ donor to
several state driver’s licenses, resulting in a deceased donor
rate that is three times that of Brazil, the United States
continues to experience a progressive increase in kidney
wait times with 7478 dialysis patients on a waiting list for
5 or more years as of 24 March 2006.2
Certainly, we regret the ‘consequences of poverty and
illiteracy’ that force more than 2 billion people to exist on
less that 1 dollar per day. Nevertheless, life today is more
than the dismal contest between ‘haves’ and ‘have nots’
potrayed by Abbud-Filho et al. Indeed, according to the
United Nations in February 2005, global life expectancy at
birth, increased from 46 years in 1950–1955 to 65 years in
2000–2005, and is expected to reach 75 years in 2045–2050.3
In the least developed countries, where life expectancy
today is just under 50 years, it is expected to be 66 years in
2045–2050. Rather than devoting total emotional energy to
squelching a dissenting point of view, it is in the best
interests of intellectual inquiry to encourage the presenta-
tion and examination of the purported benefits of a
regulated market to waiting recipients, potential paid
donors, and society. In at least one country where ‘official’
governmental policy sanctions the selling of kidneys from
both living and deceased donors, there is no longer a
waiting list for potential recipients.4
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To the Editor: We applaud Kidney International for the
publication of the exchange of views on payments to organ
donors. Although we appreciate Dr Delmonico’s lifetime of
efforts on behalf of transplant patients and we realize that this
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